Author: Atri, Lavannya; Morgan, Michael; Harrell, Sean; AlJaroudi, Wael; Berman, Adam E
                    Title: Role of cardiac magnetic resonance imaging in the diagnosis and management of COVID-19 related myocarditis: Clinical and imaging considerations  Cord-id: hmszsl8h  Document date: 2021_9_28
                    ID: hmszsl8h
                    
                    Snippet: There is a growing evidence of cardiovascular complications in coronavirus disease 2019 (COVID-19) patients. As evidence accumulated of COVID-19 mediated inflammatory effects on the myocardium, substantial attention has been directed towards cardiovascular imaging modalities that facilitate this diagnosis. Cardiac magnetic resonance imaging (CMRI) is the gold standard for the detection of structural and functional myocardial alterations and its role in identifying patients with COVID-19 mediated
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: There is a growing evidence of cardiovascular complications in coronavirus disease 2019 (COVID-19) patients. As evidence accumulated of COVID-19 mediated inflammatory effects on the myocardium, substantial attention has been directed towards cardiovascular imaging modalities that facilitate this diagnosis. Cardiac magnetic resonance imaging (CMRI) is the gold standard for the detection of structural and functional myocardial alterations and its role in identifying patients with COVID-19 mediated cardiac injury is growing. Despite its utility in the diagnosis of myocardial injury in this population, CMRI’s impact on patient management is still evolving. This review provides a framework for the use of CMRI in diagnosis and management of COVID-19 patients from the perspective of a cardiologist. We review the role of CMRI in the management of both the acutely and remotely COVID-19 infected patient. We discuss patient selection for this imaging modality; T1, T2, and late gadolinium enhancement imaging techniques; and previously described CMRI findings in other cardiomyopathies with potential implications in COVID-19 recovered patients.
 
  Search related documents: 
                                Co phrase  search for related documents- active infection and acute myocarditis: 1
  - active infection and acute phase: 1, 2, 3, 4, 5, 6, 7
  - active infection and acute setting: 1, 2, 3
  - active infection and acutely ill: 1, 2, 3
  - active infection and long term outcome: 1
  - active infection and long term sequelae: 1
  - active infection and longitudinal strain: 1
  - active infection and magnetic resonance: 1, 2, 3, 4
  - acute phase and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - acute phase and long term sequelae: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
  - acute phase and longitudinal strain: 1, 2, 3, 4, 5, 6, 7
  - acute phase and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
  - acute setting and long term outcome: 1, 2
  - acute setting and long term sequelae: 1
  - acute setting and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - acutely ill and long term outcome: 1
  - acutely ill and long term sequelae: 1
  - acutely ill and magnetic resonance: 1
  - acutely ill patient and magnetic resonance: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date